The DOI matches its Crossref record; 19 of the 19 references it cites were found in a registry or an index.
CD28-B7 blockade after alloantigenic challenge in vivo inhibits Th1 cytokines but spares Th2.
Open accessAbstract
Blocking the CD28-B7 T cell costimulatory pathway with the fusion protein CTLA4Ig inhibits alloimmune responses in vitro and in vivo and induces tolerance to cardiac allografts in mice and rats, but the mechanisms mediating the tolerant state in vivo are unknown. Here, we report the effects and potential mechanisms of CTLA4Ig in the rat renal allograft model. LEW rats were nephrectomized and received renal allografts from major histocompatibility complex-incompatible WF rats. While all untreated and control immunoglobulin (Ig)-treated animals acutely rejected their allografts and died, 86% of rats that received a single injection of CTLA4Ig on day 2 after transplantation had prolonged survival (> 60-100 days) with preserved renal function. By contrast, only 29% of animals that received CTLA4Ig on the day of engraftment had prolonged survival. Long-term survivors (> 100 days) exhibited donor-specific tolerance, accepting donor-matched WF but acutely rejecting third-party BN cardiac allografts. Immunohistological analysis of grafts sampled at 1 week after transplantation showed that both control and CTLA4Ig-treated animals had mononuclear cell infiltrates, with a higher percentage of CD4+ cells in the CTLA4Ig-treated group. However, while this was associated with vasculitis and tubulitis in control grafts, there was no evidence of tissue injury in CTLA4Ig-treated animals. The immune response leading to graft rejection in control animals was characterized by expression of the T helper (Th) type 1 cytokines interleukin (IL)-2 and interferon-gamma. In contrast, the persistent CD4+ infiltrate without graft rejection in CTLA4Ig-treated animals was associated with increased staining for the Th2-related cytokines IL-4 and IL-10. Furthermore, grafts from CTLA4Ig-treated animals had marked upregulation of intragraft staining for IgG1, but not IgG2a or IgG2b. Administration of rIL-2 to CTLA4Ig-treated animals restored allograft rejection in 50% of animals tested. These results confirm that blockade of the CD28-B7 pathway after alloantigenic challenge induces donor-specific acceptance of vascularized organ allografts, and indicates in this model that CTLA4Ig inhibits Th1 but spares Th2 cytokines in vivo.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Role of the CD28 Receptor During T Cell Responses to Antigen
Linsley, P. S., & Ledbetter, J. A. (1993) · Annual Review of Immunology · doi:10.1146/annurev.iy.11.040193.001203 · Cited by 1,298
Self-citationSchwartz, R. H. (1992) · Cell · doi:10.1016/s0092-8674(05)80055-8 · Cited by 1,293
Long-Term Survival of Xenogeneic Pancreatic Islet Grafts Induced by CTLA4lg
Lenschow, D. J., Zeng, Y., Thistlethwaite, J. R., Montag, A., Brady, W., Gibson, M. G., Linsley, P. S., & Bluestone, J. A. (1992) · Science · doi:10.1126/science.1323143 · Cited by 1,121
Self-citationHeterogeneity of Cytokine Secretion Patterns and Functions of Helper T Cells
Mosmann, T. R., & Coffman, R. L. (1989) · Advances in Immunology · doi:10.1016/s0065-2776(08)60652-5 · Cited by 1,106
Immunosuppression in Vivo by a Soluble Form of the CTLA-4 T Cell Activation Molecule
Linsley, P. S., Wallace, P. M., Johnson, J., Gibson, M. G., Greene, J. L., Ledbetter, J. A., Singh, C., & Tepper, M. A. (1992) · Science · doi:10.1126/science.1496399 · Cited by 790
Self-citationKhoury, S. J., Hancock, W. W., & Weiner, H. L. (1992) · The Journal of Experimental Medicine · doi:10.1084/jem.176.5.1355 · Cited by 708
Self-citationT-cell activation by the CD28 ligand B7 is required for cardiac allograft rejection in vivo.
Turka, L. A., Linsley, P. S., Lin, H., Brady, W., Leiden, J. M., Wei, R. Q., Gibson, M. L., Zheng, X. G., Myrdal, S., & Gordon, D. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.22.11102 · Cited by 533
Self-citationLin, H., Bolling, S. F., Linsley, P. S., Wei, R. Q., Gordon, D., Thompson, C. B., & Turka, L. A. (1993) · The Journal of experimental medicine · doi:10.1084/jem.178.5.1801 · Cited by 485
Self-citationProstaglandin E2 differentially modulates cytokine secretion profiles of human T helper lymphocytes
Snijdewint, F. G., Kaliński, P., Wierenga, E. A., Bos, J. D., & Kapsenberg, M. L. (1993) · The Journal of Immunology · doi:10.4049/jimmunol.150.12.5321 · Cited by 477
Tan, P., Anasetti, C., Hansen, J. A., Melrose, J., Brunvand, M., Bradshaw, J., Ledbetter, J. A., & Linsley, P. S. (1993) · The Journal of experimental medicine · doi:10.1084/jem.177.1.165 · Cited by 461
Self-citationTRANSPLANTATION TOLERANCE INDUCED BY CTLA4-Ig1
Pearson, T. C., Alexander, D. Z., Winn, K. J., Linsley, P. S., Lowry, R. P., & Larsen, C. P. (1994) · Transplantation · doi:10.1097/00007890-199406270-00002 · Cited by 298
Self-citationTRANSPLANTATION TOLERANCE INDUCED BY CTLA4-Ig1
Pearson, T. C., Alexander, D. Z., Winn, K. J., Linsley, P. S., Lowry, R. P., & Larsen, C. P. (1994) · Transplantation · doi:10.1097/00007890-199457120-00002 · Cited by 295
Self-citationSeder, R. A., Germain, R. N., Linsley, P. S., & Paul, W. E. (1994) · The Journal of experimental medicine · doi:10.1084/jem.179.1.299 · Cited by 205
Self-citationBoussiotis, V. A., Freeman, G. J., Gribben, J. G., Daley, J., Gray, G., & Nadler, L. M. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.23.11059 · Cited by 203
Isolation and characterization of dendritic cells from mouse heart and kidney.
Austyn, J. M., Hankins, D. F., Larsen, C. P., Morris, P. J., Rao, A. S., & Roake, J. A. (1994) · The Journal of Immunology · doi:10.4049/jimmunol.152.5.2401 · Cited by 174
McArthur, J. G., & Raulet, D. H. (1993) · The Journal of Experimental Medicine · doi:10.1084/jem.178.5.1645 · Cited by 106
Lü, P., Zhou, X., Chen, S.-J., Moorman, M. A., Morris, S. C., Finkelman, F. D., Linsley, P. S., Urban, J. F., & Gause, W. C. (1994) · The Journal of Experimental Medicine · doi:10.1084/jem.180.2.693 · Cited by 106
Self-citationKhoury, S. J., Sayegh, M. H., Hancock, W. W., Gallon, L. G., Carpenter, C. B., & Weiner, H. L. (1993) · The Journal of Experimental Medicine · doi:10.1084/jem.178.2.559 · Cited by 66
Self-citationHancock, W. W., Khoury, S. J., Carpenter, C. B., & Sayegh, M. H. (1994) · PubMed · Cited by 40
Self-citation
Cited by
CD28/B7 SYSTEM OF T CELL COSTIMULATION
Lenschow, D. J., Walunas, T. L., & Bluestone, J. A. (1996) · Annual Review of Immunology · doi:10.1146/annurev.immunol.14.1.233 · Cited by 2,717
INDUCTION OF TH1 AND TH2 CD4+T CELL RESPONSES:The Alternative Approaches
Constant, S. L., & Bottomly, K. (1997) · Annual Review of Immunology · doi:10.1146/annurev.immunol.15.1.297 · Cited by 1,459
CTLA4-Ig and anti-CD40 ligand prevent renal allograft rejection in primates
Kirk, A. D., Harlan, D. M., Armstrong, N. N., Davis, T. A., Dong, Y., Gray, G. S., Hong, X., Thomas, D., Fechner, J. H., & Knechtle, S. J. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.16.8789 · Cited by 929
IL-10 Is Required for Regulatory T Cells to Mediate Tolerance to Alloantigens In Vivo
Hara, M., Kingsley, C. I., Niimi, M., Read, S., Turvey, S. E., Bushell, A. R., Morris, P. J., Powrie, F., & Wood, K. J. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.166.6.3789 · Cited by 766
Larsen, C. P., Pearson, T. C., Adams, A. B., Tso, P., Shirasugi, N., Strobertb, E., Anderson, D., Cowan, S., Price, K., Naemura, J., et al. (2005) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2005.00749.x · Cited by 723
Self-citation
Metadata
- Authors
- Sayegh, M. H., Akalin, E., Hancock, W. W., Russell, M. E., Carpenter, C. B., Linsley, P. S., & Turka, L. A.
- Venue
- The Journal of experimental medicine
- Publisher
- Rockefeller University Press
- Published
- 1995-05-01
- Volume
- 181
- Issue
- 5
- Pages
- 1869-1874
- ISSN
- 0022-1007 (ISSN-L)
- 1540-9538
- OpenAlex
- W2103806658
- Cited by
- 511
- References
- 19
- FWCI
- 20.51
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.